Imeik Technology Development Co.,Ltd.
300896
Classificação em ações
#3929
Imeik Technology Development Co.,Ltd. specializes in the research, development,... Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
Preço da ação
$13.90
Valor de mercado
$4.21B
Variação (1 dia)
-3.01%
Variação (1 ano)
-41.01%
País
CN
Negociar Imeik Technology Development Co.,Ltd. (300896)
Categoria
Healthcare
Rácio P/S de Imeik Technology Development Co.,Ltd. (300896)
Rácio P/S em October 2026 TTM: 12.08
De acordo com os relatórios financeiros mais recentes e o preço das ações da Imeik Technology Development Co.,Ltd., o rácio P/S atual (TTM) é 12.08. No final de 2023, o rácio P/S era 21.54.
Histórico do rácio P/S da Imeik Technology Development Co.,Ltd. de 2014 a 2026
Rácio P/S no final de cada ano
| Ano | Rácio P/S | Alterar |
|---|---|---|
| 2026 (TTM) | 12.08 | -33.52% |
| 2024 | 18.17 | -15.66% |
| 2023 | 21.54 | -52.29% |
| 2022 | 45.14 | -21.11% |
| 2021 | 57.22 | -27.83% |
| 2020 | 79.29 | 51.44% |
| 2019 | 52.36 | -22.85% |
| 2018 | 67.86 | -31.18% |
| 2017 | 98.61 | -33.64% |
| 2016 | 148.61 | -20.55% |
| 2015 | 187.04 | -32.82% |
| 2014 | 278.39 | 0.00% |
Rácio P/S de empresas semelhantes ou concorrentes
| Empresa | Rácio P/S | Diferença do rácio P/S | País |
|---|---|---|---|
| 13.45 | 11.38% |
US
|
|
| 2.32 | -80.76% |
FR
|
|
| - | - |
JP
|
|
| 2.47 | -79.56% |
US
|
|
| - | - |
CH
|
